Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal. hyperplastic, and neoplastic endometrium - Enhanced expression by endometrial adenocarcinomas is associated with low differentiation
M. Maatta et al., Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal. hyperplastic, and neoplastic endometrium - Enhanced expression by endometrial adenocarcinomas is associated with low differentiation, AM J CLIN P, 114(3), 2000, pp. 402-411
Citations number
34
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
We studied membrane-type matrix metalloproteinnse-1 (MT1-MMP), tissue inhib
itor of metalloproteinase-1 (TIMP-1), TIMP-2 and TIMP-3 messenger RNA (mRNA
) using in situ hybridization to elucidate their temporal and spatial expre
ssion patterns in normal, hyperplastic, and neoplastic endometrium. All mRN
As studied were expressed weakly, in proliferating endometrium but were ind
uced strongly in late secretory endometrium except MT1-MMP Endometrial hype
rplasia samples did not show increased MT1-MMP or TIMP mRNA expression, ind
icating that the overall expression patterns in hyperplasia are comparable
to those in proliferating endometrium under estrogen effect and that synthe
sis of extracellular matrix proteins, rather than degradation, predominates
in this condition. Exceptionally, stromal cells in areas of desquamation w
ere seen to express focally, intense MT1-MMP mRNA in hyperplasia samples. A
ll mRNAs investigated It ere expressed increasingly in endometrial adenocar
cinomas, especially in less differentiated carcinomas. Furthermore, gelatin
zymography revealed higher functional degradative activities in carcinoma
tissues than in normal endometrium. Our results indicate that MT1-MMP expre
ssion, together with that of TIMPs, is involved most notably in normal endo
metrium under progesterone effect and, without being connected to cyclic ho
rmonal levels, has an important role in the invasive growth of endometrial
adenocarcinomas.